Endothelial nitric oxide synthase overexpression by neuronal cells in neurodegeneration: a link between inflammation and neuroprotection

The roles of neuronal and inducible nitric oxide synthases in neurones have been extensively investigated; by contrast, the biological significance of endothelial nitric oxide synthase (eNOS) overexpression that occurs in several pathological conditions has not yet been studied. We have started addressing this issue in a cell model of neurodegeneration, i.e. human SKNBE neuroblastoma cells transfected with a mutant form of alsin, a protein causing an early‐onset type of amyotrophic lateral sclerosis, ALS2. We found that eNOS, which is endogenously expressed by these cells, was activated by tumour necrosis factor‐α (TNF‐α), a proinflammatory cytokine that plays important roles in ALS2 and several neurodegenerative diseases. The TNF‐α‐dependent eNOS activation occurred through generation, by sphingosine‐kinase‐1, of sphingosine‐1‐phosphate, stimulation of its membrane receptors and activation of Akt, as determined using small interference RNA and dominant negative constructs specific for the enzymes and receptors. eNOS activation by TNF‐α conferred cytoprotection from excitotoxicity and neurotoxic cues such as reactive oxygen species, endoplasmic reticulum stress, DNA damage, and mutated alsin itself. Our results suggest that overexpression of eNOS by neurones is a broad‐range protective mechanism activated during damage and establish a link of pathophysiological relevance between this enzyme and inflammation accompanying neurodegenerative diseases. These findings also question the concept that high NO output in the presence of oxidative stress leads always to peroxynitrite formation contributing to neurodegeneration.

[1]  S. Wedgwood,et al.  Protein kinase C (cid:1) regulates endothelial nitric oxide synthase expression via Akt activation and nitric oxide generation , 2008 .

[2]  G. Kroemer,et al.  Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis , 2008, Oncogene.

[3]  D. Butterfield,et al.  Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity , 2007, Nature Reviews Neuroscience.

[4]  T. Michel,et al.  Life history of eNOS: partners and pathways. , 2007, Cardiovascular research.

[5]  Asako Otomo,et al.  Molecular and cellular function of ALS2/alsin: Implication of membrane dynamics in neuronal development and degeneration , 2007, Neurochemistry International.

[6]  S. Fulda,et al.  Activation of Akt predicts poor outcome in neuroblastoma. , 2007, Cancer research.

[7]  E. Clementi,et al.  Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy , 2006, Journal of Cell Science.

[8]  W. Robberecht,et al.  The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. , 2006, Biochimica et biophysica acta.

[9]  Robert H. Brown,et al.  Molecular biology of amyotrophic lateral sclerosis: insights from genetics , 2006, Nature Reviews Neuroscience.

[10]  J. Rothstein,et al.  Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1G93A mice , 2006, Experimental Neurology.

[11]  R. Oppenheim,et al.  Complete Dissociation of Motor Neuron Death from Motor Dysfunction by Bax Deletion in a Mouse Model of ALS , 2006, The Journal of Neuroscience.

[12]  Shijie Jin,et al.  Tumor Necrosis Factor-α Induces Neurotoxicity via Glutamate Release from Hemichannels of Activated Microglia in an Autocrine Manner* , 2006, Journal of Biological Chemistry.

[13]  Katalin Bartus,et al.  Signaling from Blood Vessels to CNS Axons through Nitric Oxide , 2006, The Journal of Neuroscience.

[14]  N. Bresolin,et al.  The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function. , 2006, Brain : a journal of neurology.

[15]  A. Nehlig,et al.  Role of endothelial nitric oxide synthase in cerebral blood flow changes during kainate seizures: A genetic approach using knockout mice , 2006, Neurobiology of Disease.

[16]  S. Moncada,et al.  Nitric oxide, cell bioenergetics and neurodegeneration , 2006, Journal of neurochemistry.

[17]  B. Pettmann,et al.  Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Potashkin,et al.  The role of oxidative stress in the dysregulation of gene expression and protein metabolism in neurodegenerative disease. , 2006, Antioxidants & redox signaling.

[19]  S. Rivest,et al.  Tumor Necrosis Factor α But Not Interleukin 1β Mediates Neuroprotection in Response to Acute Nitric Oxide Excitotoxicity , 2006, The Journal of Neuroscience.

[20]  E. Clementi,et al.  Endothelial Nitric Oxide Synthase Activation by Tumor Necrosis Factor α Through Neutral Sphingomyelinase 2, Sphingosine Kinase 1, and Sphingosine 1 Phosphate Receptors: A Novel Pathway Relevant to the Pathophysiology of Endothelium , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[21]  L. Defebvre,et al.  Elevated IL-6 and TNF-α levels in patients with ALS: Inflammation or hypoxia? , 2005, Neurology.

[22]  John Calvin Reed,et al.  Endoplasmic reticulum stress: cell life and death decisions. , 2005, The Journal of clinical investigation.

[23]  C. Estrada,et al.  Nitric Oxide and Adult Neurogenesis in Health and Disease , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[24]  L. Martin,et al.  Adult Motor Neuron Apoptosis Is Mediated by Nitric Oxide and Fas Death Receptor Linked by DNA Damage and p53 Activation , 2005, The Journal of Neuroscience.

[25]  M. Chopp,et al.  Endothelial Nitric Oxide Synthase Regulates Brain-Derived Neurotrophic Factor Expression and Neurogenesis after Stroke in Mice , 2005, The Journal of Neuroscience.

[26]  R. Nixon Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases , 2005, Neurobiology of Aging.

[27]  K. Lesch,et al.  Differential effect of endothelial nitric oxide synthase (NOS‐III) on the regulation of adult neurogenesis and behaviour , 2004, The European journal of neuroscience.

[28]  K. Schlett,et al.  Tumor Necrosis Factor (TNF)-mediated Neuroprotection against Glutamate-induced Excitotoxicity Is Enhanced by N-Methyl-D-aspartate Receptor Activation , 2004, Journal of Biological Chemistry.

[29]  L. Bruijn,et al.  Unraveling the mechanisms involved in motor neuron degeneration in ALS. , 2004, Annual review of neuroscience.

[30]  Roland N. Emokpae,et al.  Cell Cycle Activation Linked to Neuronal Cell Death Initiated by DNA Damage , 2004, Neuron.

[31]  Wenzheng Zhang,et al.  Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide. , 2003, American journal of physiology. Renal physiology.

[32]  M. Ebadi,et al.  Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease. , 2003, Antioxidants & redox signaling.

[33]  A. Futerman,et al.  The roles of ceramide and complex sphingolipids in neuronal cell function. , 2003, Pharmacological research.

[34]  S. M. Gibbs Regulation of neuronal proliferation and differentiation by nitric oxide , 2003, Molecular Neurobiology.

[35]  D. Gozal,et al.  VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death. , 2003, Brain research. Molecular brain research.

[36]  H. Bading,et al.  The Yin and Yang of NMDA receptor signalling , 2003, Trends in Neurosciences.

[37]  H. Ischiropoulos,et al.  Oxidative stress and nitration in neurodegeneration: cause, effect, or association? , 2003, The Journal of clinical investigation.

[38]  E. Clementi,et al.  Cyclic GMP-dependent inhibition of acid sphingomyelinase by nitric oxide: an early step in protection against apoptosis , 2002, Cell Death and Differentiation.

[39]  L. Acarín,et al.  Decrease of Proinflammatory Molecules Correlates With Neuroprotective Effect of the Fluorinated Salicylate Triflusal After Postnatal Excitotoxic Damage , 2002, Stroke.

[40]  M. Strong,et al.  Activated microglia (BV-2) facilitation of TNF-α-mediated motor neuron death in vitro , 2002, Journal of Neuroimmunology.

[41]  M. Goligorsky,et al.  Relationships between caveolae and eNOS: everything in proximity and the proximity of everything. , 2002, American journal of physiology. Renal physiology.

[42]  Dennis Brown And now for something completely different , 2002 .

[43]  P. Mander,et al.  Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration , 2002, Neuroscience.

[44]  P. Ghezzi,et al.  Tumor Necrosis Factor and Motoneuronal Degeneration: An Open Problem , 2002, Neuroimmunomodulation.

[45]  K. Kashiwado,et al.  Expression of nitric oxide synthases in the anterior horn cells of amyotrophic lateral sclerosis , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[46]  W. Sessa,et al.  Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? , 2001, The Journal of pharmacology and experimental therapeutics.

[47]  J. Julien,et al.  Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor-α , 2001, The Journal of cell biology.

[48]  D. Macgowan,et al.  An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy , 2001, Neurology.

[49]  T. Ben-Hur,et al.  Expression of endothelial nitric oxide synthase in the ischemic penumbra: relationship to expression of neuronal nitric oxide synthase and vascular endothelial growth factor , 2001, Brain Research.

[50]  C. Cooper,et al.  Nitric oxide synthases: structure, function and inhibition , 2001 .

[51]  P. Neumann,et al.  Role of ecNOS-derived NO in mediating TNF-induced endothelial barrier dysfunction. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[52]  E. Clementi,et al.  Activation of the Endothelial Nitric-oxide Synthase by Tumor Necrosis Factor-α , 2001, The Journal of Biological Chemistry.

[53]  D. Feinstein,et al.  Expression and function of inducible nitric oxide synthase in neurons , 2001, Journal of Neuroimmunology.

[54]  J. Gamble,et al.  Expression of a Catalytically Inactive Sphingosine Kinase Mutant Blocks Agonist-induced Sphingosine Kinase Activation , 2000, The Journal of Biological Chemistry.

[55]  J. Loeffler,et al.  Alteration of the Bcl-x/Bax Ratio in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis: Evidence for the Implication of the p53 Signaling Pathway , 2000, Neurobiology of Disease.

[56]  A. Höke,et al.  Transient action of the endothelial constitutive nitric oxide synthase (ecNOS) mediates the development of thermal hypersensitivity following peripheral nerve injury , 2000, The European journal of neuroscience.

[57]  E. Clementi,et al.  Nitric oxide inhibits tumor necrosis factor-alpha-induced apoptosis by reducing the generation of ceramide. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[58]  J. Wands,et al.  Aberrant expression of nitric oxide synthase III in Alzheimer’s disease: relevance to cerebral vasculopathy and neurodegeneration , 2000, Neurobiology of Aging.

[59]  S. Rogers,et al.  Inflammatory Cytokines IL-1α, IL-1β, IL-6, and TNF-α Impart Neuroprotection to an Excitotoxin Through Distinct Pathways , 1999, The Journal of Immunology.

[60]  J. Stamler,et al.  NO: an inhibitor of cell death , 1999, Cell Death and Differentiation.

[61]  S. Przedborski,et al.  Inducible Nitric Oxide Synthase Up‐Regulation in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis , 1999, Journal of neurochemistry.

[62]  R. E. Brown,et al.  Mice deficient in endothelial nitric oxide synthase exhibit a selective deficit in hippocampal long-term potentiation , 1999, Neuroscience.

[63]  R. Mannucci,et al.  Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. , 1999, Gastroenterology.

[64]  J. Wands,et al.  Neuritic sprouting with aberrant expression of the nitric oxide synthase III gene in neurodegenerative diseases , 1999, Journal of the Neurological Sciences.

[65]  D. Seol,et al.  Nitric Oxide Suppression of Apoptosis Occurs in Association with an Inhibition of Bcl-2 Cleavage and Cytochrome cRelease* , 1998, The Journal of Biological Chemistry.

[66]  Xing-li Wang,et al.  Nitric oxide induces and inhibits apoptosis through different pathways , 1998, FEBS letters.

[67]  E. Clementi,et al.  Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[68]  E. Clementi,et al.  Autocrine Nitric Oxide Modulates CD95-induced Apoptosis in γδ T Lymphocytes* , 1997, The Journal of Biological Chemistry.

[69]  M. Dubois‐Dauphin,et al.  Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. , 1997, Science.

[70]  M. Sporn,et al.  Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease , 1996, The Journal of experimental medicine.

[71]  David W. Anderson,et al.  Altered expression of bcl‐2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons , 1996, Annals of neurology.

[72]  T. Koepsell,et al.  Incidence of amyotrophic lateral sclerosis in three counties in western Washington state , 1996, Neurology.

[73]  J. Garthwaite,et al.  Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase , 1995, Neuroscience.

[74]  E. Clementi,et al.  Growth factor-induced Ca2+ responses are differentially modulated by nitric oxide via activation of a cyclic GMP-dependent pathway. , 1995, Molecular pharmacology.

[75]  D. Hanley,et al.  Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains , 1994, Annals of neurology.

[76]  M. Yoshizumi,et al.  Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. , 1993, Circulation research.

[77]  INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .

[78]  W. Bradley,et al.  Mitochondrial involvement in amyotrophic lateral sclerosis , 2007, Molecular Neurobiology.

[79]  S. Rivest,et al.  Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[80]  L. Defebvre,et al.  Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia? , 2005, Neurology.

[81]  D. Steensma,et al.  Flow cytometric methods for detection and quantification of apoptosis. , 2003, Methods in molecular medicine.

[82]  M. Strong,et al.  Activated microglia (BV-2) facilitation of TNF-alpha-mediated motor neuron death in vitro. , 2002, Journal of neuroimmunology.

[83]  C. Cooper,et al.  Nitric oxide synthases: structure, function and inhibition. , 2001, The Biochemical journal.

[84]  S. Hadano,et al.  A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 , 2001, Nature Genetics.

[85]  S. Rogers,et al.  Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. , 1999, Journal of immunology.

[86]  E. Clementi,et al.  Autocrine nitric oxide modulates CD95-induced apoptosis in gammadelta T lymphocytes. , 1997, The Journal of biological chemistry.

[87]  J Garthwaite,et al.  Nitric oxide signaling in the central nervous system. , 1995, Annual review of physiology.

[88]  S. Snyder,et al.  Nitric oxide: a neural messenger. , 1995, Annual review of cell and developmental biology.